Novartis Bioventures Ltd 13D/13G Filings for

Novartis Bioventures Ltd 13D and 13G filings for :

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-11
4:32 pm
Sale
2021-12-3113GBicycle Therapeutics plc
BCYC
Novartis Bioventures Ltd673,360
2.290%
-967,786decrease
(-58.97%)
Filing
2021-02-01
5:14 pm
Sale
2020-12-3113GBicycle Therapeutics plc
BCYC
Novartis Bioventures Ltd1,641,146
7.700%
-126,995decrease
(-7.18%)
Filing